Detalhe da pesquisa
1.
Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells.
Biochem Biophys Res Commun
; 662: 76-83, 2023 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099813
2.
Efficient mRNA delivery system utilizing chimeric VSVG-L7Ae virus-like particles.
Biochem Biophys Res Commun
; 505(4): 1097-1102, 2018 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30316514
3.
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells.
Nat Biomed Eng
; 7(1): 24-37, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509913
4.
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application.
Mol Ther Methods Clin Dev
; 26: 15-25, 2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35755947
5.
Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
STAR Protoc
; 2(4): 100965, 2021 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34825222
6.
Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells.
Nat Biomed Eng
; 5(5): 429-440, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002062
7.
Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein.
Stem Cell Reports
; 16(4): 985-996, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711268
8.
iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity.
Stem Cell Reports
; 14(1): 49-59, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883921
9.
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.
Nat Commun
; 11(1): 1334, 2020 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170079
10.
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.
Nat Commun
; 10(1): 5302, 2019 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811138
11.
Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility.
Cell Stem Cell
; 24(4): 566-578.e7, 2019 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853558
12.
Site-specific randomization of the endogenous genome by a regulatable CRISPR-Cas9 piggyBac system in human cells.
Sci Rep
; 8(1): 310, 2018 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29321585
13.
Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.
Stem Cells Int
; 2017: 8765154, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28607562